default author photo

Aya Mizuike

National Institute of Infectious Diseases

1-23-1 Toyama Shinjuku Yokyo

Japan

SCHOLARLY PAPERS

1

DOWNLOADS

213

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Optimised Lipid Nanoparticle-mRNA Vaccine Design: Minimising Pyrogenicity While Preserving Immunogenicity Through Immune Profiling

Number of pages: 63 Posted: 27 Feb 2025
National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Waseda University, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, National Institute of Infectious Diseases, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo Shinagawa Hospital, National Institute of Infectious Diseases, National Institute of Infectious Diseases, National Institute of Infectious Diseases, National Institute of Infectious Diseases, The University of Tokyo, The University of Tokyo, The University of Tokyo, The University of Tokyo, The University of Tokyo, Waseda University, National Institute of Infectious Diseases, Tokyo Shinagawa Hospital, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development and National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development
Downloads 213 (357,858)

Abstract:

Loading...

mRNA vaccine, lipid nanoparticle, ionisable lipid, vaccine reactogenicity, interleukin-1